Pre-eclampsia is one of the most common pregnancy complications, and a major cause of
fetal and maternal morbidity and mortality globally. Diagnosis currently takes place in the …

The early identification of women with an increased risk of preeclampsia (PE) is desirable,
but apart from soluble fms-like tyrosine kinase-1 (sFlt-1), few biomarkers have previously …

Previous studies have shown that per-and polyfluoroalkyl substances (PFAS) may have
hepatotoxic effects in animals. However, epidemiological evidence in humans, especially …

To elucidate whether uric acid changes in early pregnancy are associated with the
development of preeclampsia and their association with preeclampsia-related adverse …

(1) Background: Pregnancy-induced hypertension (PIH) is associated with obvious
microbiota dysbiosis in the third trimester of pregnancy. However, the mechanisms behind …

Background Gestational hypertension (GH) and preeclampsia (PE) are severe adverse
gestational complications. Previous studies supported potential link between elevated liver …

Background: Hyperuricemia is a common laboratory finding in pregnant women
compromised by preeclampsia. A growing body of evidence suggests that uric acid is …

Abstract Background Abnormal myocardial Nav1. 5 expression and function cause lethal
ventricular arrhythmias during myocardial ischemia–reperfusion (I/R). Protein inhibitor of …

Purpose To investigate additional potential clinical risk factors for preeclampsia. Methods
This is a nested case–control study of preeclampsia and unaffected pregnancies. Cases …

This study aimed to evaluate the association between maternal liver biomarkers in early
pregnancy and the risk of hypertensive disorders of pregnancy (HDP), as well as to evaluate …